{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:29:55Z","timestamp":1785493795687,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02007-6","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:16:44Z","timestamp":1774063004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer\u2019s disease patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Adriana","family":"Gea-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Valle-Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"L\u00f3pez-Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"S\u00e1ez-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Salud","family":"Garc\u00eda-Ayll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"2007_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer\u2019s disease. Lancet. 2016;388:505\u201317.","journal-title":"Lancet"},{"key":"2007_CR2","doi-asserted-by":"publisher","first-page":"19235","DOI":"10.1074\/jbc.R116.746032","volume":"291","author":"RJ Andrew","year":"2016","unstructured":"Andrew RJ, Kellett KAB, Thinakaran G, Hooper NM. A Greek tragedy: the growing complexity of Alzheimer amyloid precursor protein proteolysis. J Biol Chem. 2016;291:19235\u201344.","journal-title":"J Biol Chem"},{"key":"2007_CR3","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","volume":"96","author":"S Lammich","year":"1999","unstructured":"Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M. Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A. 1999;96:3922\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2007_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2:a006270.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2007_CR5","doi-asserted-by":"crossref","unstructured":"Peron R, Vatanabe IP, Manzine PR, Camins A, Cominetti MR. Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer\u2019s Disease Treatment. Pharmaceuticals (Basel). 2018;11(1):12.","DOI":"10.3390\/ph11010012"},{"key":"2007_CR6","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","volume":"18","author":"M Kim","year":"2009","unstructured":"Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, et al. Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate \u03b1-secretase activity. Hum Mol Genet. 2009;18:3987\u201396.","journal-title":"Hum Mol Genet"},{"key":"2007_CR7","first-page":"3","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 2019. 2019;51:3.","journal-title":"Nat Genet 2019"},{"key":"2007_CR8","doi-asserted-by":"crossref","unstructured":"Ag\u00fcero P, Sainz MJ, Garc\u00eda-Ayll\u00f3n MS, S\u00e1ez-Valero J, T\u00e9llez R, Guerrero-L\u00f3pez R, et al. \u03b1-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):139.","DOI":"10.1186\/s13195-020-00708-0"},{"key":"2007_CR9","first-page":"3","volume":"25","author":"D Hartl","year":"2018","unstructured":"Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry 2018. 2018;25:3.","journal-title":"Mol Psychiatry 2018"},{"key":"2007_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1096\/fj.01-0007fje","volume":"15","author":"A Anders","year":"2001","unstructured":"Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F. Regulation of the \u03b1-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 2001;15:1837\u20139.","journal-title":"FASEB J"},{"key":"2007_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11033-008-9224-5","volume":"36","author":"X Li","year":"2009","unstructured":"Li X, Yan Y, Huang W, Yang Y, Wang H, Chang L. The regulation of TACE catalytic function by its prodomain. Mol Biol Rep. 2009;36:641\u201351.","journal-title":"Mol Biol Rep"},{"key":"2007_CR12","doi-asserted-by":"publisher","first-page":"11738","DOI":"10.1074\/jbc.M805894200","volume":"284","author":"T Tousseyn","year":"2009","unstructured":"Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, et al. ADAM10, the Rate-limiting Protease of Regulated Intramembrane Proteolysis of Notch and Other Proteins, Is Processed by ADAMS-9, ADAMS-15, and the \u03b3-Secretase. J Biol Chem. 2009;284:11738\u201347.","journal-title":"J Biol Chem"},{"key":"2007_CR13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1471-4159.2009.05907.x","volume":"108","author":"E Parkin","year":"2009","unstructured":"Parkin E, Harris B. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J Neurochem. 2009;108:1464\u201379.","journal-title":"J Neurochem"},{"key":"2007_CR14","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.3390\/ijms24076113","volume":"24","author":"P Ag\u00fcero-Rabes","year":"2023","unstructured":"Ag\u00fcero-Rabes P, P\u00e9rez-P\u00e9rez J, Cremades-Jimeno L, Garc\u00eda-Ayll\u00f3n MS, Gea-Gonz\u00e1lez A, Sainz MJ, et al. ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels. Int J Mol Sci. 2023;24:6113.","journal-title":"Int J Mol Sci"},{"key":"2007_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1255-9","volume":"15","author":"A Sogorb-Esteve","year":"2018","unstructured":"Sogorb-Esteve A, Garc\u00eda-Ayll\u00f3n MS, Gobom J, Alom J, Zetterberg H, Blennow K, et al. Levels of ADAM10 are reduced in Alzheimer\u2019s disease CSF. J Neuroinflammation. 2018;15:1\u20139.","journal-title":"J Neuroinflammation"},{"key":"2007_CR16","doi-asserted-by":"crossref","unstructured":"Cuchillo-Iba\u00f1ez I, Lopez-Font I, Boix-Amor\u00f3s A, Brinkmalm G, Blennow K, Molinuevo JL et al. Heteromers of amyloid precursor protein in cerebrospinal fluid. Mol Neurodegener;10:1\u201311.","DOI":"10.1186\/1750-1326-10-2"},{"key":"2007_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00540","volume":"9","author":"WH Huang","year":"2018","unstructured":"Huang WH, Chen W, Jiang LY, Yang YX, Yao LF, Li KS. Influence of ADAM10 polymorphisms on plasma level of soluble receptor for advanced glycation end products and the association with Alzheimer\u2019s disease risk. Front Genet. 2018;9:404273.","journal-title":"Front Genet"},{"key":"2007_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03402076","volume":"8","author":"F Colciaghi","year":"2002","unstructured":"Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, et al. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med. 2002;8:67.","journal-title":"Mol Med"},{"key":"2007_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/acssensors.9b02463","volume":"5","author":"TR De Oliveira","year":"2020","unstructured":"De Oliveira TR, Erbereli CR, Manzine PR, Magalh\u00e3es TNC, Balthazar MLF, Cominetti MR, et al. Early Diagnosis of Alzheimer\u2019s Disease in Blood Using a Disposable Electrochemical Microfluidic Platform. ACS Sens. 2020;5:1010\u20139.","journal-title":"ACS Sens"},{"key":"2007_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-69","volume":"6","author":"H Jiang","year":"2011","unstructured":"Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, et al. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease. Mol Neurodegener. 2011;6:1\u20138.","journal-title":"Mol Neurodegener"},{"key":"2007_CR21","first-page":"57","volume":"10","author":"L Bai","year":"2013","unstructured":"Bai L, Song N, Yu J, Tan L, Shen Y, Xie J, et al. Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer\u2019s disease patients of Northern Han Chinese descent. Curr Alzheimer Res. 2013;10:57\u201362.","journal-title":"Curr Alzheimer Res"},{"key":"2007_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3233\/JAD-140177","volume":"41","author":"Q Sun","year":"2014","unstructured":"Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, et al. Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2014;41:877\u201386.","journal-title":"J Alzheimers Dis"},{"key":"2007_CR23","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 1991 82:4. 1991;82:239\u201359.","DOI":"10.1007\/BF00308809"},{"key":"2007_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5:228\u201334.","journal-title":"Lancet Neurol"},{"key":"2007_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-1-59745-542-8_51","volume":"536","author":"ST Mathews","year":"2009","unstructured":"Mathews ST, Plaisance EP, Kim T. Imaging systems for westerns: chemiluminescence vs. infrared detection. Methods Mol Biol. 2009;536:499\u2013513.","journal-title":"Methods Mol Biol"},{"key":"2007_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2144\/00293pf02","volume":"29","author":"JC Gingrich","year":"2000","unstructured":"Gingrich JC, Davis DR, Nguyen Q. Multiplex detection and quantitation of proteins on western blots using fluorescent probes. Biotechniques. 2000;29:636\u201342.","journal-title":"Biotechniques"},{"key":"2007_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1640090","volume":"16","author":"L Liu","year":"2025","unstructured":"Liu L, Tian E, Quan S, Su C, Zhou J, Hu S, et al. ADAM17 as a promising therapeutic target: from structural basis to inhibitor discovery in human diseases. Front Pharmacol. 2025;16:1640090.","journal-title":"Front Pharmacol"},{"key":"2007_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-150737","volume":"50","author":"F Schuck","year":"2016","unstructured":"Schuck F, Wolf D, Fellgiebel A, Endres K. Increase of \u03b1-secretase ADAM10 in platelets along cognitively healthy aging. J Alzheimers Dis. 2016;50:817\u201326.","journal-title":"J Alzheimers Dis"},{"key":"2007_CR29","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1073\/pnas.0813167106","volume":"106","author":"A Rath","year":"2009","unstructured":"Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci U S A. 2009;106:1760\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2007_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ab.2012.11.007","volume":"434","author":"A Rath","year":"2013","unstructured":"Rath A, Deber CM. Correction factors for membrane protein molecular weight readouts on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem. 2013;434:67\u201372.","journal-title":"Anal Biochem"},{"key":"2007_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11357-008-9076-x","volume":"31","author":"HG Bernstein","year":"2008","unstructured":"Bernstein HG, Stricker R, Lendeckel U, Bertram I, Dobrowolny H, Steiner J, et al. Reduced neuronal co-localisation of nardilysin and the putative \u03b1-secretases ADAM10 and ADAM17 in Alzheimer\u2019s disease and Down syndrome brains. Age (Omaha). 2008;31:11.","journal-title":"Age (Omaha)"},{"key":"2007_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/ijms23031539","volume":"23","author":"A Maio","year":"2022","unstructured":"Maio A, De Di A, Pelucchi S, Garofalo M, Marciano B, Nuzzo T, et al. Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson\u2019s and Alzheimer\u2019s Disease Patients. Int J Mol Sci. 2022;23:1539.","journal-title":"Int J Mol Sci"},{"key":"2007_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/1567205014666170203093219","volume":"14","author":"B Shackleton","year":"2017","unstructured":"Shackleton B, Crawford F, Bachmeier C. Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer\u2019s disease. Curr Alzheimer Res. 2017;14:578\u201385.","journal-title":"Curr Alzheimer Res"},{"key":"2007_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fnmol.2017.00056","volume":"10","author":"K Endres","year":"2017","unstructured":"Endres K, Deller T. Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms. Front Mol Neurosci. 2017;10:56.","journal-title":"Front Mol Neurosci"},{"key":"2007_CR35","first-page":"1","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammar\u00e9n HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:1\u201316.","journal-title":"Nat Commun"},{"key":"2007_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00018-020-03507-w","volume":"78","author":"A Seifert","year":"2021","unstructured":"Seifert A, D\u00fcsterh\u00f6ft S, Wozniak J, Koo CZ, Tomlinson MG, Nuti E, et al. The metalloproteinase ADAM10 requires its activity to sustain surface expression. Cell Mol Life Sci. 2021;78:715\u201332.","journal-title":"Cell Mol Life Sci"},{"key":"2007_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.bbagen.2008.03.004","volume":"1780","author":"C Escrevente","year":"2008","unstructured":"Escrevente C, Morais VA, Keller S, Soares CM, Altevogt P, Costa J. Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. Biochim Biophys Acta. 2008;1780:905\u201313.","journal-title":"Biochim Biophys Acta"},{"key":"2007_CR38","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1046\/j.1471-4159.1999.721600.x","volume":"72","author":"J S\u00e1ez-Valero","year":"1999","unstructured":"S\u00e1ez-Valero J, Sberna G, McLean CA, Small DH. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurochem. 1999;72:1600\u20138.","journal-title":"J Neurochem"},{"key":"2007_CR39","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1073\/pnas.0601279103","volume":"103","author":"A Botella-L\u00f3pez","year":"2006","unstructured":"Botella-L\u00f3pez A, Burgaya F, Gav\u00edn R, Garc\u00eda-Ayll\u00f3n MS, G\u00f3mez-Tortosa E, Pe\u00f1a-Casanova J, et al. Reelin expression and glycosylation patterns are altered in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103:5573\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2007_CR40","doi-asserted-by":"crossref","unstructured":"Boix CP, Lopez-Font I, Cuchillo-Iba\u00f1ez I, S\u00e1ez-Valero J. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):96.","DOI":"10.1186\/s13195-020-00664-9"},{"key":"2007_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10456-014-9443-4","volume":"18","author":"V Caolo","year":"2015","unstructured":"Caolo V, Swennen G, Chalaris A, Wagenaar A, Verbruggen S, Rose-John S, et al. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis. Angiogenesis. 2015;18:13\u201322.","journal-title":"Angiogenesis"},{"key":"2007_CR42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/emmm.201200214","volume":"4","author":"N Kakuda","year":"2012","unstructured":"Kakuda N, Shoji M, Arai H, Furukawa K, Ikeuchi T, Akazawa K, et al. Altered \u03b3-secretase activity in mild cognitive impairment and Alzheimer\u2019s disease. EMBO Mol Med. 2012;4:344\u201352.","journal-title":"EMBO Mol Med"},{"key":"2007_CR43","doi-asserted-by":"publisher","first-page":"627e27","DOI":"10.1016\/j.neurobiolaging.2011.04.006","volume":"33","author":"M-X Silveyra","year":"2012","unstructured":"Silveyra M-X, Garc\u00eda-Ayll\u00f3n M-S, Serra-Basante C, Mazzoni V, Garc\u00eda-Gutierrez M-S, Manzanares J, et al. Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels. Neurobiol Aging. 2012;33:627e27.","journal-title":"Neurobiol Aging"},{"key":"2007_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12035-015-9644-x","volume":"54","author":"M-S Garc\u00eda-Ayll\u00f3n","year":"2017","unstructured":"Garc\u00eda-Ayll\u00f3n M-S, Botella-L\u00f3pez A, Cuchillo-Iba\u00f1ez I, R\u00e1bano A, Andreasen N, Blennow K, et al. HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer\u2019s Disease Brain. Mol Neurobiol. 2017;54:188\u201399.","journal-title":"Mol Neurobiol"},{"key":"2007_CR45","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1096\/fj.201700736RR","volume":"32","author":"T Mata-Balaguer","year":"2018","unstructured":"Mata-Balaguer T, Cuchillo-Iba\u00f1ez I, Calero M, Ferrer I, S\u00e1ez-Valero J. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer\u2019s disease. FASEB J. 2018;32:3536\u201346.","journal-title":"FASEB J"},{"key":"2007_CR46","doi-asserted-by":"crossref","unstructured":"Cuchillo-Iba\u00f1ez I, Lennol MP, Escamilla S, Mata-Balaguer T, Valverde-Vozmediano L, Lopez-Font I, et al. The apolipoprotein receptor LRP3 compromises APP levels. Alzheimers Res Ther. 2021;13(1):181.","DOI":"10.1186\/s13195-021-00921-5"},{"key":"2007_CR47","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid \u03b2 protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62:788\u2013801.","journal-title":"Neuron"},{"key":"2007_CR48","doi-asserted-by":"crossref","unstructured":"Swirski M, Miners JS, De Silva R, Lashley T, Ling H, Holton J, et al. Evaluating the relationship between amyloid-\u03b2 and \u03b1-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther. 2014;6(5\u20138):77.","DOI":"10.1186\/s13195-014-0077-y"},{"key":"2007_CR49","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.1007\/s12035-025-04895-5","volume":"62","author":"E Keske","year":"2025","unstructured":"Keske E, Ebrahimi A, Sa\u011flam U\u00e7ar \u00d6. Amyloid-\u03b2-induced neurotoxicity modulates miR-98 and miR-200 expression in SH-SY5Y cells: a step toward Alzheimer\u2019s biomarker discovery. Mol Neurobiol. 2025;62:10201\u20139.","journal-title":"Mol Neurobiol"},{"key":"2007_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.852738","volume":"10","author":"M Antonino","year":"2022","unstructured":"Antonino M, Marmo P, Freites CL, Quassollo GE, S\u00e1nchez MF, Lorenzo A, et al. A\u03b2 assemblies promote amyloidogenic processing of APP and intracellular accumulation of A\u03b242 through Go\/G\u03b2\u03b3 signaling. Front Cell Dev Biol. 2022;10:852738.","journal-title":"Front Cell Dev Biol"},{"key":"2007_CR51","doi-asserted-by":"publisher","first-page":"15239","DOI":"10.3390\/ijms232315239","volume":"23","author":"YT Hsiao","year":"2022","unstructured":"Hsiao YT, Huang YT, Yu HJ, Fang PC, Kuo MT. Tear proteomics approach to distinguishing primary from secondary Sj\u00f6gren\u2019s syndrome for dry eye patients with long-term instillation of eyedrops. Int J Mol Sci. 2022;23:15239.","journal-title":"Int J Mol Sci"},{"key":"2007_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106826","volume":"140","author":"N Gruba","year":"2023","unstructured":"Gruba N, Piwkowska A, Lesner A. Initial study of the detection of ADAM 10 in the urine of type-2 diabetic patients. Bioorg Chem. 2023;140:106826.","journal-title":"Bioorg Chem"},{"key":"2007_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-017-0070-5","volume":"14","author":"C Conrad","year":"2017","unstructured":"Conrad C, Dorzweiler K, Miller MA, Lauffenburger DA, Strik H, Bartsch JW. Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis. Fluids Barriers CNS. 2017;14:1\u20139.","journal-title":"Fluids Barriers CNS"},{"key":"2007_CR54","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/BJ20051013","volume":"393","author":"A Stoeck","year":"2006","unstructured":"Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, Le Naour F, et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J. 2006;393:609\u201318.","journal-title":"Biochem J"},{"key":"2007_CR55","doi-asserted-by":"publisher","first-page":"111303","DOI":"10.1016\/j.exger.2021.111303","volume":"149","author":"IP Vatanabe","year":"2021","unstructured":"Vatanabe IP, Pedroso RV, Manzine PR, Chagas MHN, de Morais Fabr\u00edcio D, Grigoli MM, et al. ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty. Exp Gerontol. 2021;149:111303.","journal-title":"Exp Gerontol"},{"key":"2007_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-130125","volume":"36","author":"PR Manzine","year":"2013","unstructured":"Manzine PR, Barham EJ, Vale FDAC, Do, Selistre-De-Ara\u00fajo HS, Iost Pavarini SC, Cominetti MR. Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2013;36:253\u201360.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2007_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/gps.4020","volume":"29","author":"PR Manzine","year":"2014","unstructured":"Manzine PR, Barham EJ, Vale FAC, Selistre-De-Ara\u00fajo HS, Pavarini SCI, Cominetti MR. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2014;29:414\u201320.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2007_CR58","doi-asserted-by":"crossref","unstructured":"Oliveira Monteiro MPA, Salheb Oliveira DSM, Manzine PR, Crispim Nascimento CM, dos, Santos Orlandi AA, de Oliveira Gomes GA et al. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study. Alzheimers Res Ther. 2021;13:1\u20138.","DOI":"10.1186\/s13195-020-00750-y"},{"key":"2007_CR59","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/ijms22052416","volume":"22","author":"IP Vanatabe","year":"2021","unstructured":"Vanatabe IP, Peron R, Grigoli MM, Pelucchi S, De Cesare G, Magalh\u00e3es T, et al. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22:2416.","journal-title":"Int J Mol Sci"},{"key":"2007_CR60","first-page":"2082","volume":"1864","author":"K Reiss","year":"2017","unstructured":"Reiss K, Bhakdi S. The plasma membrane: Penultimate regulator of ADAM sheddase function. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res. 2017;1864:2082\u20137.","journal-title":"Mol Cell Res"},{"key":"2007_CR61","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1007\/s12035-019-01677-8","volume":"56","author":"I Lopez-Font","year":"2019","unstructured":"Lopez-Font I, Boix CP, Zetterberg H, Blennow K, S\u00e1ez-Valero J. Characterization of Cerebrospinal Fluid BACE1 Species. Mol Neurobiol. 2019;56:8603\u201316.","journal-title":"Mol Neurobiol"},{"key":"2007_CR62","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Ayll\u00f3n M-S, Campanari M-L, Brinkmalm G, R\u00e1bano A, Alom J, Saura CA, et al. CSF Presenilin-1 complexes are increased in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2013;1:1\u201313.","DOI":"10.1186\/2051-5960-1-46"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02007-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02007-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02007-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:07:50Z","timestamp":1777435670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02007-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2007"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02007-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee at the Hospital General Universitario de Elche (PI 21\/2022) and the Miguel Hernandez University (IN.JSV.02:20) and it was carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}